Aurobindo Pharma Ltd.

View in App
1131.30 +27.90 ▲2.5%

26 April 2024, 04:02:40 PM
Volume: 1,511,617

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.aurobindo.com
Market Cap 66,278.45 Cr.
Enterprise Value(EV) 65,452.22 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 47.28 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 23.92 Trailing Twelve Months Ending 2023-12
Industry PE 41.99 Trailing Twelve Months Ending 2023-12
Book Value / Share 497.17 Trailing Twelve Months Ending 2023-12
Price to Book Value 2.28 Calculated using Price: 1,131.15
Dividend Yield 0.27 Period Ending 2023-03
No. of Shares Subscribed 58.59 Cr. 585,938,609 Shares
FaceValue 1
About Aurobindo Pharma Ltd.
Aurobindo Pharma continues to be one of the world's fastest growing Active Pharmaceutical Ingredients (API) manufacturing companies, driven by cost leadership, flexibility to produce multiple products in the same manufacturing facilities and capabilities in various therapeutic domains. Its API business has ensured the profitability and growth of its formulations business through seamless vertical integration. Its API business is supported by technologically advanced research and development infrastructure, which develops new products and plays a role in the delivery of products to the market. It has built a strong presence in key therapeutic segments such as Central nervous system (CNS), cardiovascular (CVS), anti-retroviral (ARV), anti-diabetics, gastroenterology and antibiotics. Also, it is building a diversified pipeline in high-margin specialty generic formulations segment.

Aurobindo Pharma Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Aurobindo Pharma Ltd. Performance

View details >>
1 Day
+2.53%
1 Week
+1.51%
1 Month
+10.93%
3 Month
-1.70%
6 Month
+31.38%
1 Year
+88.39%
2 Year
+77.07%
5 Year
+42.20%
10 Year
+290.60%

Aurobindo Pharma Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 35.29 32.53 27.63 23.02 18.49 18.52 27.53 11.38 7.5
Return on Capital Employed (%) 27.18 27.36 24.96 22.74 17.98 18.72 30.1 12.71 9.39
Return on Assets (%) 14.03 14.14 14.47 13.09 10.02 10.33 17.16 7.9 5.29

Aurobindo Pharma Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 5,156 7,287 9,372 11,680 13,891 16,825 21,930 24,576 26,840 28,189
Non Curr. Liab. 1,592 584 102 594 358 555 807 903 867 1,734
Curr. Liab. 6,136 7,840 6,606 8,666 12,021 11,385 10,665 8,156 11,494 13,012
Minority Int. 26 3 2 2 2 0 -1 -2 12 6
Equity & Liab. 12,910 15,714 16,082 20,942 26,271 28,765 33,401 33,633 39,213 42,941
Non Curr. Assets 4,611 5,420 6,875 8,764 10,939 12,352 13,578 15,510 17,667 19,386
Curr. Assets 8,299 10,294 9,206 12,178 15,332 16,413 19,740 18,044 21,460 23,555
Misc. Exp. not W/O
Total Assets 12,910 15,714 16,082 20,942 26,271 28,765 33,401 33,633 39,213 42,941

Aurobindo Pharma Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 12,121 13,795 14,910 16,463 19,564 23,099 24,775 23,455 24,855 27,895
Other Income 97 204 116 102 155 192 381 323 291 601
Total Income 12,217 13,998 15,025 16,565 19,719 23,290 25,155 23,778 25,146 28,495
Total Expenditure -9,557 -10,607 -11,475 -12,691 -15,612 -18,234 -19,441 -19,071 -21,137 -22,766
PBIDT 2,660 3,392 3,550 3,874 4,107 5,056 5,714 4,707 4,009 5,729
Interest -160 -257 -67 -78 -263 -305 -74 -49 -140 -256
Depreciation -333 -392 -428 -558 -668 -967 -1,055 -1,127 -1,245 -1,513
Taxation -597 -721 -760 -818 -727 -899 -2,010 -726 -685 -1,113
Exceptional Items -88 -26 2,815 -128 -70
PAT 1,571 2,024 2,301 2,423 2,365 2,844 5,334 2,647 1,928 2,778
Minority Interest 5 2 0 0 0 1 1 1 0 3
Share Associate -10
Other Related Items
Consolidated Net Profit 1,576 2,025 2,302 2,423 2,365 2,845 5,335 2,648 1,928 2,770
Adjusted EPS 27 35 39 41 40 49 91 45 33 47

Aurobindo Pharma Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 646 1,237 1,420 3,279 1,955 1,651 4,381 3,329 5,016 2,387
Cash Fr. Inv. -819 -1,398 -1,445 -1,787 -1,927 -2,903 -1,568 599 -3,212 -3,978
Cash Fr. Finan. 118 93 365 -1,915 864 1,919 -1,947 -1,365 -2,969 1,814
Net Change -55 -68 340 -424 892 667 866 2,563 -1,164 223
Cash & Cash Eqvt 148 461 744 320 1,210 1,876 2,747 5,330 4,163 4,392

Aurobindo Pharma Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 51.83 51.83 51.83 51.83 51.83 51.83 51.83 51.83 51.83
Public 48.17 48.17 48.17 48.17 48.17 48.17 48.17 48.17 48.17
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 14.05 14.97 14.92 16.15 17.90 19.16 19.56 18.90 20.86
No. of Shareholders (in Lacs)

Aurobindo Pharma Ltd. Announcements

View details >>
Tue, 23 Apr 2024
Loss/Duplicate-Share Certificate-XBRL
AUROBINDO PHARMA LIMITED has informed the Exchange about Issue of duplicate share certificates/Letter of Confirmation
Tue, 23 Apr 2024
Loss of Share Certificates
Aurobindo Pharma Limited has informed the Exchange about Loss of Share Certificates
Mon, 22 Apr 2024
Loss/Duplicate-Share Certificate-XBRL
AUROBINDO PHARMA LIMITED has informed the Exchange about Loss of share certificates

Aurobindo Pharma Ltd. Technical Scans

View details >>
Fri, 26 Apr 2024
Closing Above Previous High Closing Above Previous High
Making Higher Highs for 3 days Making Higher Highs for 3 days
Close Within 52 Week High Zone Close Within 52 Week High Zone
Closing Above Previous High for 2 Days Closing Above Previous High for 2 Days
Making Higher Highs for 2 Days Making Higher Highs for 2 Days

Aurobindo Pharma Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 360,919.96 1,506.55 -0.9%
Cipla Ltd. 113,794.25 1,409.15 +0.2%
Divi's Laboratories Ltd. 106,860.39 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. 104,315.63 6,252.10 +0.5%
Zydus Lifesciences Ltd. 95,380.92 947.40 -0.4%
Mankind Pharma Ltd. 94,869.36 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. 91,057.05 2,691.00 -0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.52 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-12 30.69 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-12 77.27 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.95 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.07 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-12 54.93 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 60.95 2,691.00 -0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.78 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-12 4.39 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-12 8.20 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.88 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.06 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-12 10.68 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.73 2,691.00 -0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 0.02 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,691.00 -0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,691.00 -0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,691.00 -0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,691.00 -0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,691.00 -0.1%

Aurobindo Pharma Ltd. FAQ's

What is Aurobindo Pharma share price?
Can I buy Aurobindo Pharma shares now?
What is the Dividend Yield of Aurobindo Pharma?
What is the Market Cap of Aurobindo Pharma?
What are the key metrics to analyse Aurobindo Pharma?
What is the 52 Week High and Low of Aurobindo Pharma?
What is the trend of Aurobindo Pharma share price?